A second-grade teacher and grandmother experienced ambiguous symptoms like fatigue, back pain and weight loss. They were signs of advanced pancreatic cancer.

“No one is promised tomorrow. Why waste the days I’ve been given stressing about death?” Katie Thurston tells PEOPLE Allison Michael Orenstein As 2025 dawned, Katie Thurston was feeling beyond lucky ...

The family of a new dad who died at just 33-years-old from bile-duct cancer have hit out at health officials who rejected the use of a potentially life-saving treatment on the NHS .

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have found that depleting a clotting protein made by the liver could slow down pancreatic cancer. The research, ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Until now, the following has been true for metastatic pancreatic cancer: Once the tumor has spread, local treatment such as surgery is usually no longer an option. In recent years, however, studies ...

A woman with cancer that spread to her liver is getting a second chance at life after receiving a partial liver transplant from a living donor. Amy Piccioli told "Good Morning America" doctors have ...

“When a doctor tells you it’s stage 4, you think, ‘My life is over,'" said Amy Piccioli ...

FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...

In an effort to catch one of the deadliest cancers in the world early, Taiwan's national academy, Academia Sinica, and the National Taiwan University Hospital have teamed up to create a new ...

The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally advanced pancreatic cancer, in combination with gemcitabine and nab-paclitaxel.